Study Title
Phase I/II Dose-escalation Study of Fractionated and Multiple Dose 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Study Details
Description:
The purpose of the initial (phase I) portion of this study is to find a dose level and administration schedule of the study drug, 225Ac-J591 that can be given without severe side effects.
Sponsor:
Weill Medical College of Cornell University
Government Study Link:
NCT04506567 - Click here to see study onClinicalTrials.gov